Ines Moreno-Gonzalez, PhD, an adjunct associate professor of neurology, explains healthy aging can help reduce lifestyle risk factors for Alzheimer disease.
In a randomized clinical trial, researchers determined the safety and efficacy of semorinemab, a monoclonal anti-tai antibody, in prodromal to mild AD.
Maternal genetic liability to neurodevelopmental conditions is associated with several pregnancy-related factors previously thought to be associated with those conditions.